Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHEK1 | O14757 | 1/20 | 0.61 |
| ▸ | ABL1 | P00519 | 1/20 | 0.61 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.61 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.61 |
| ▸ | FLT1 | P17948 | 1/20 | 0.61 |
| ▸ | GRK5 | P34947 | 1/20 | 0.61 |
| ▸ | KDR | P35968 | 1/20 | 0.61 |
| ▸ | MAP2K2 | P36507 | 1/20 | 0.61 |
| ▸ | CDK8 | P49336 | 1/20 | 0.61 |
| ▸ | GSK3A | P49840 | 1/20 | 0.61 |
| ▸ | GSK3B | P49841 | 1/20 | 0.61 |
| ▸ | PRKX | P51817 | 1/20 | 0.61 |
| ▸ | NEK2 | P51955 | 1/20 | 0.61 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.61 |
| ▸ | MAP2K1 | Q02750 | 1/20 | 0.61 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.61 |
| ▸ | MAP4K2 | Q12851 | 1/20 | 0.61 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.61 |
| ▸ | IKBKE | Q14164 | 1/20 | 0.61 |
| ▸ | NTRK3 | Q16288 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14665692 | 0.90 | SMN1; SMN2 (0.66) | CHEK1ABL1PDGFRBPDGFRAFLT1 | |
| SCHEMBL17166610 | 0.84 | CLK4 (0.55) | CHEK1ABL1PDGFRBPDGFRAFLT1 | |
| SCHEMBL11344932 | 0.82 | ALDH1A1 (0.58) | CHEK1ABL1PDGFRBPDGFRAFLT1 | |
| SCHEMBL2658676 | 0.81 | CLK4 (0.66) | CHEK1ABL1PDGFRBPDGFRAFLT1 | |
| SCHEMBL24689623 | 0.80 | CHEK1 (0.47) | CHEK1ABL1PDGFRBPDGFRAFLT1 | |
| SCHEMBL11709927 | 0.78 | ADORA2A (0.56) | CHEK1ABL1PDGFRBPDGFRAFLT1 | |
| SCHEMBL14665733 | 0.78 | CHEK1 (0.49) | CHEK1ABL1PDGFRBPDGFRAFLT1 | |
| SCHEMBL11333718 | 0.77 | ALDH1A1 (0.50) | CHEK1ABL1PDGFRBPDGFRAFLT1 | |
| SCHEMBL23009767 | 0.76 | L3MBTL1 (0.56) | CHEK1ABL1PDGFRBPDGFRAFLT1 | |
| SCHEMBL12388028 | 0.75 | TDP1 (0.58) | ALDH1A1ADORA2AADORA1NPSR1ADORA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4243101-A1 | ORGANIC LIGHT-EMITTING DEVICE | Lg Chem, Ltd. (KR) | 2023-09-13 | — | — | EP | disclosed |
| EP-4242205-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | Lg Chem, Ltd. (KR) | 2023-09-13 | — | — | EP | disclosed |
| WO-2022191488-A1 | ORGANIC LIGHT-EMITTING DEVICE | 주식회사 엘지화학 | 2022-09-15 | — | — | WO | disclosed |
| WO-2022191681-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | 주식회사 엘지화학 | 2022-09-15 | — | — | WO | disclosed |
| US-8053573-B2 | Monomer 5, 6-diphenyl-1.2.4-traizinic derivatives and the use thereof | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2011-11-08 | — | — | US | disclosed |
| EP-2107122-A1 | Protease detection material, set of protease detection materials, and method for measuring protease | FUJIFILM Corporation (JP) | 2009-10-07 | — | — | EP | disclosed |
| US-20080299055-A1 | Monomer 5, 6-Diphenyl-1.2.4-Traizinic Derivatives and the Use Thereof | PIERRE FABRE DERMO-COSMETIQUE (FR) | 2008-12-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080299055-A1 | Monomer 5, 6-Diphenyl-1.2.4-Traizinic Derivatives and the Use Thereof | POT1, TELO2, CLIC1 | CHEK1 168/4885ABL1 1085/4885PDGFRB 629/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.